Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 4Psychological Well-Being 2Neoplasms 2Depression 2Anxiety Disorders 2Signs and Symptoms 1Motor Activity 1Fatigue 1Colon Cancer Screening 1Breast Cancer Female 1

Interventions

pembrolizumab 180Gemcitabine 168Paclitaxel 150Carboplatin 134Bevacizumab 126Cisplatin 113Docetaxel 112Cyclophosphamide 109Exercise 97Nivolumab 93Fluorouracil 88Capecitabine 85Dexamethasone 81Irinotecan 74Radiotherapy 68Oxaliplatin 68Pemetrexed 66Standard of Care 64Leucovorin 63Cetuximab 59Sorafenib 53Erlotinib Hydrochloride 53Drug Therapy 53Blood Specimen Collection 51Doxorubicin 50atezolizumab 48trametinib 47Ipilimumab 47Albumin-Bound Paclitaxel 44130-nm albumin-bound paclitaxel 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Neoplasms × Self-Help Groups × Clear all
NCT04659993 2025-10-16

Cancer Within a Pandemic: A Telemental Health Intervention

Wake Forest University Health Sciences

Phase NA Terminated
10 enrolled 10 charts

Anxiety Disorders, Depression, Neoplasms

NCT01919853 2025-07-02

Treatment for Persistently Fatigued Cancer Survivors: A Randomized Controlled Trial With Biomarker Response

Indiana University

Phase NA Completed
107 enrolled

Fatigue, Neoplasms, Signs and Symptoms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡